Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -269,949 | -237,734 | -129,874 | -79,413 | -110,715 |
| Depreciation Amortization | -15,115 | -10,968 | 45 | 1,085 | 576 |
| Accounts payable and accrued liabilities | -73 | -12,040 | 11,524 | 1,655 | -426 |
| Other Working Capital | 9,598 | -9,425 | 15,962 | 1,724 | 4,427 |
| Other Operating Activity | 43,220 | 85,997 | 8,505 | 20,368 | 76,359 |
| Operating Cash Flow | $-232,319 | $-184,170 | $-93,838 | $-54,581 | $-29,779 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -228,140 | -93,354 | -114,329 | -74,033 | -79,807 |
| PPE Investments | -511 | -898 | -797 | -259 | -42 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 29,371 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3 |
| Investing Cash Flow | $-228,651 | $-94,252 | $-115,126 | $-74,292 | $-50,481 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,726 |
| Debt Issued | N/A | 15,000 | 5,000 | N/A | N/A |
| Common Stock Issued | 459,678 | 146,793 | 295,754 | 116,593 | 25,104 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -44 |
| Other Financing Activity | -1,941 | 63,877 | 21,490 | 8,682 | 74,525 |
| Financing Cash Flow | $457,737 | $225,670 | $322,244 | $125,275 | $101,311 |
| Beginning Cash Position | 102,827 | 155,579 | 42,299 | 45,897 | 24,846 |
| End Cash Position | 99,594 | 102,827 | 155,579 | 42,299 | 45,897 |
| Net Cash Flow | $-3,233 | $-52,752 | $113,280 | $-3,598 | $21,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -232,319 | -184,170 | -93,838 | -54,581 | -29,779 |
| Capital Expenditure | -511 | -898 | -797 | -338 | -42 |
| Free Cash Flow | -232,830 | -185,068 | -94,635 | -54,919 | -29,821 |